Allarity Therapeutics ALLR
NASDAQ ALLR
$0.88 +0.00 (+0.32%)
At close: Oct 20, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Net Margin (2020 - 2026)

Updated

Allarity Therapeutics' Net Margin was -11000.00% in Q1 2026.

Analysis

Allarity Therapeutics (ALLR) Net Margin (2020 - 2026) Analysis & Trends

For FY2025, Net Margin at Allarity Therapeutics came in at -3509.69%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 21.86%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 21.27%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -8.04%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 16.30%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -134.51%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -1.65%
10 Allarity Therapeutics 13.89 Mn -54.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -11,000.00%
Sep 30, 2021 -4,825.00%
Sep 30, 2020 -677.83%
API Access

Allarity Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ALLR&period=max&api_key=YOUR_API_KEY